Exploring Emotional Regulation, Depression, Impulsivity, and Anxiety Connected to Attention Deficit Hyperactivity Disorder with Substance Use

Jamuna Das; Jitendriya Biswal; Rakesh Mohanty

doi:10.54133/ajms.v8i2.1737

Authors

Jamuna Das Department of Psychiatry, IMS & SUM Hospitals (SOA deemed to be University), Bhubaneswar, Odisha, India https://orcid.org/0009-0009-1280-3488
Jitendriya Biswal Department of Psychiatry, IMS & SUM Hospitals (SOA deemed to be University), Bhubaneswar, Odisha, India https://orcid.org/0000-0003-4343-4880
Rakesh Mohanty Department of Psychiatry, IMS & SUM Hospitals (SOA deemed to be University), Bhubaneswar, Odisha, India

DOI:

https://doi.org/10.54133/ajms.v8i2.1737

Keywords:

Anxiety, Emotional dysregulation, Depression, Impulsivity

Abstract

Background: Emotional regulation difficulties, depression, impulsivity, and anxiety are psychological factors that frequently co-occur with substance use in attention deficit hyperactivity disorder. These factors contribute to maladaptive coping strategies, increasing vulnerability to substance use patterns. Objective: To explore the psychological factors of the co-occurrence of ADHD with substance use, with a specific focus on emotional regulation, depression, impulsiveness, and anxiety. Methods: This cross-sectional study, conducted from September 2023 to September 2024 at a university in Eastern Odisha, explored psychological factors among undergraduate students aged 18–26 with ADHD and co-occurring substance use. Data collection utilizes validated tools, including ASRS-V1.1, ASSIST, HAM-D, HAM-A, DERS, and BIS. Results: The study analyzed 1,310 undergraduate students, showing 8.2% with ADHD, of which 52.3% reported substance use (SU). Impulsivity was significantly associated with SU, with higher impulsivity reported in SU individuals. Anxiety also showed a strong association with SU. However, emotional dysregulation and depression were not significantly linked to SU. These findings highlight key psychological factors influencing substance use in ADHD. Conclusions: This study underscores the significant role of impulsiveness and anxiety in the co-occurrence of substance use (SU) among individuals with ADHD, while emotional dysregulation and depression were not found to have a significant association. These findings highlight the need for targeted interventions addressing impulsiveness and anxiety to mitigate the risk of SU in this population.

Downloads

Download data is not yet available.

References

Magnus W, Anilkumar AC, Shaban K. Attention deficit hyperactivity disorder. 2023 Aug 8. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 28722868

Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010;122:97. doi: 10.3810/PGM.2010.09.2206. DOI: https://doi.org/10.3810/pgm.2010.09.2206

Klassen LJ, Bilkey TS, Katzman MA, Chokka P. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. Curr Drug Abuse Rev. 2012;5:190–198. doi: 10.2174/1874473711205030190. DOI: https://doi.org/10.2174/1874473711205030190

Molina BSG, Pelham WE. Attention-deficit/hyperactivity disorder and risk of substance use disorder: Developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol. 2014;10:607. doi: 10.1146/ANNUREV-CLINPSY-032813-153722. DOI: https://doi.org/10.1146/annurev-clinpsy-032813-153722

Samal B, Senjam G, Ravan JR, Ningombam HS, Das RC, Das SK. Prevalence of adult ADHD in patients with substance use disorder in North East India. Ind Psychiatry J. 2022;31:214–220. doi: 10.4103/ipj.ipj_250_21. DOI: https://doi.org/10.4103/ipj.ipj_250_21

Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, et al. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement. World J Psychiatry. 2023;13:84–112. doi: 10.5498/wjp.v13.i3.84. DOI: https://doi.org/10.5498/wjp.v13.i3.84

Kumar PPC, Antony S, Ammapattian T, Kishor M, Sadashiv M. Substance use prevalence and associated factors among Indian college students: A narrative review. Arch Mental Health. 2024;25(1):77–84. doi: 10.4103/amh.amh_58_23. DOI: https://doi.org/10.4103/amh.amh_58_23

Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, et al. Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 2006;18:145–148. doi: 10.1080/10401230600801077. DOI: https://doi.org/10.1080/10401230600801077

World Health Organization. The Alcohol, smoking and substance involvement screening test (ASSIST): Manual for use in primary care. 2010. Available from: https://www.who.int/publications/i/item/978924159938-2

Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103:1039–1047. doi: 10.1111/J.1360-0443.2007.02114.X. DOI: https://doi.org/10.1111/j.1360-0443.2007.02114.x

Renemane L, Vrublevska J, (Eds.), Hamilton depression rating scale: Uses and applications. The Neuroscience of Depression, (1st Ed.), 2021:175–83. doi: 10.1016/B978-0-12-817933-8.00019-0. DOI: https://doi.org/10.1016/B978-0-12-817933-8.00019-0

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi: 10.1136/jnnp.23.1.56. DOI: https://doi.org/10.1136/jnnp.23.1.56

Schneider H, Esbitt S, Gonzalez JS. Hamilton Anxiety Rating Scale. In: Gellman MD, Turner JR, (Eds.), Encyclopedia of Behavioral Medicine. Springer, New York, NY. 2013. doi: 10.1007/978-1-4419-1005-9_197. DOI: https://doi.org/10.1007/978-1-4419-1005-9_197

Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Lond). 2015;65(7):601. doi: 10.1093/occmed/kqv054. DOI: https://doi.org/10.1093/occmed/kqv054

Gómez-Peresmitré G, Platas Acevedo RS, Gómez-Peresmitré G, Platas Acevedo RS. DERSR-B. A brief scale for detection of emotional dysregulation risk. Acta Investig Psicol. 2023;13:5–18. doi: 10.22201/FPSI.20074719E.2023.2.491. DOI: https://doi.org/10.22201/fpsi.20074719e.2023.2.491

Hallion LS, Steinman SA, Tolin DF, Diefenbach GJ. Psychometric properties of the difficulties in emotion regulation scale (DERS) and its short forms in adults with emotional disorders. Front Psychol. 2018;9:289634. doi: 10.3389/FPSYG.2018.00539/BIBTEX. DOI: https://doi.org/10.3389/fpsyg.2018.00539

Martínez-Loredo V, Fernández-Hermida JR, Fernández-Artamendi S, Carballo JL, García-Rodríguez O. Spanish adaptation and validation of the Barratt Impulsiveness Scale for early adolescents (BIS-11-A). Int J Clin Health Psychol. 2015;15:274–282. doi: 10.1016/J.IJCHP.2015.07.002. DOI: https://doi.org/10.1016/j.ijchp.2015.07.002

Barratt ES. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep. 1965;16:547–554. doi: 10.2466/PR0.1965.16.2.547. DOI: https://doi.org/10.2466/pr0.1965.16.2.547

Mitchell JT, Robertson CD, Anastopolous AD, Nelson-Gray RO, Kollins SH. Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary study. J Psychopathol Behav Assess. 2012;34:510–519. doi: 10.1007/s10862-012-9297-2. DOI: https://doi.org/10.1007/s10862-012-9297-2

Ahmad SI, Hinshaw SP. Attention-deficit/hyperactivity disorder, trait impulsivity, and externalizing behavior in a longitudinal sample. J Abnorm Child Psychol. 2017;45:1077. doi: 10.1007/S10802-016-0226-9. DOI: https://doi.org/10.1007/s10802-016-0226-9

Ganesan SP, Lokesh Kumar K, Chilukuri H. Relation of substance use to attention deficit hyperactivity disorder among undergraduate students: a cross-sectional survey. Int J Indian Psychol. 2021;9(1):1090-1099. doi: 10.25215/0901.114.

Doran N, Tully L. Impulsivity and tobacco product use over time. Addict Behav. 2018;85:153-157. doi: 10.1016/j.addbeh.2018.06.007. DOI: https://doi.org/10.1016/j.addbeh.2018.06.007

Weidberg S, González-Roz A, Castaño Y, Secades-Villa R. Emotion dysregulation in relation to cannabis use and mental health among young adults. Addict Behav. 2023;144:107757. doi: 10.1016/j.addbeh.2023.107757. DOI: https://doi.org/10.1016/j.addbeh.2023.107757

Tong L, Shi HJ, Zhang Z, Yuan Y, Xia ZJ, Jiang XX, et al. Mediating effect of anxiety and depression on the relationship between Attention-deficit/hyperactivity disorder symptoms and smoking/drinking. Sci Rep. 2016;6:21609. doi: 10.1038/srep21609. DOI: https://doi.org/10.1038/srep21609

Bolshakova M, Bluthenthal R, Sussman S. Opioid use and misuse: health impact, prevalence, correlates and interventions. Psychol Health. 2019;34(9):1105-1139. doi: 10.1080/08870446.2019.1622013. DOI: https://doi.org/10.1080/08870446.2019.1622013

Kozak K, Lucatch AM, Lowe DJE, Balodis IM, MacKillop J, George TP. The neurobiology of impulsivity and substance use disorders: implications for treatment. Ann N Y Acad Sci. 2018;1451:71. doi: 10.1111/NYAS.13977. DOI: https://doi.org/10.1111/nyas.13977

Kenézlői E, Balogh L, Somogyi S, Lévay EE, Halmai Z, Nemoda Z, et al. Emotion dysregulation and impulsivity as overlapping symptoms in adult Attention-Deficit/Hyperactivity Disorder and Borderline Personality Disorder: severity profiles and associations with childhood traumatization and personality functioning. Ann Gen Psychiatry. 2025;24(1):3. doi: 10.1186/s12991-024-00540-y. DOI: https://doi.org/10.1186/s12991-024-00540-y

Elzohairy NW, Elzlbany GAM, Khamis BI, El-Monshed AH, Atta MHR. Mindfulness-based training effect on attention, impulsivity, and emotional regulation among children with ADHD: The role of family engagement in randomized controlled trials. Arch Psychiatr Nurs. 2024;53:204-214. doi: 10.1016/j.apnu.2024.10.001. DOI: https://doi.org/10.1016/j.apnu.2024.10.001

Liu Q, Feng Y, Chen W, Zhu Y, Preece DA, Gao Y, et al. Emotion regulation strategy and its relationship with emotional dysregulation in children with attention-deficit/hyperactivity disorder: behavioral and brain findings. Eur Child Adolesc Psychiatry. 2025. doi: 10.1007/s00787-025-02643-7. DOI: https://doi.org/10.1007/s00787-025-02643-7

Roberts W, Peters JR, Adams ZW, Lynam DR, Milich R. Identifying the facets of impulsivity that explain the relation between ADHD symptoms and substance use in a nonclinical sample. Addict Behav. 2014;39:1272. doi: 10.1016/J.ADDBEH.2014.04.005. DOI: https://doi.org/10.1016/j.addbeh.2014.04.005

Hirsch O, Chavanon ML, Christiansen H. Emotional dysregulation subgroups in patients with adult Attention-Deficit/Hyperactivity Disorder (ADHD): a cluster analytic approach. Sci Rep. 2019;9:1–11. doi: 10.1038/s41598-019-42018-y. DOI: https://doi.org/10.1038/s41598-019-42018-y

Ware OD, Zerden LD, Duron JF, Xu Y, McCarthy LP, Verbiest S, et al. Prevalence of co-occurring conditions among youths receiving treatment with primary anxiety, ADHD, or depressive disorder diagnoses. Front Child Adolesc Psychiatr. 2024;3. doi: 10.3389/FRCHA.2024.1340480. DOI: https://doi.org/10.3389/frcha.2024.1340480